EE9700208A - Meetod gonadaalsteroid-sõltuva seisundi ravimiseks - Google Patents

Meetod gonadaalsteroid-sõltuva seisundi ravimiseks

Info

Publication number
EE9700208A
EE9700208A EE9700208A EE9700208A EE9700208A EE 9700208 A EE9700208 A EE 9700208A EE 9700208 A EE9700208 A EE 9700208A EE 9700208 A EE9700208 A EE 9700208A EE 9700208 A EE9700208 A EE 9700208A
Authority
EE
Estonia
Prior art keywords
treating
dependent condition
gonadal steroid
gonadal
steroid
Prior art date
Application number
EE9700208A
Other languages
English (en)
Other versions
EE03515B1 (et
Inventor
D. Hodgen Gary
Philips Audrey
Original Assignee
The Medical College Of Hampton Roads
Ortho Pharmaceutical Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26959766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE9700208(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/467,860 external-priority patent/US5658884A/en
Application filed by The Medical College Of Hampton Roads, Ortho Pharmaceutical Corporation filed Critical The Medical College Of Hampton Roads
Publication of EE9700208A publication Critical patent/EE9700208A/et
Publication of EE03515B1 publication Critical patent/EE03515B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
EE9700208A 1994-07-22 1995-07-18 GnRH antagonist kasutamiseks gonadaalsteroid-sõltuva seisundi ravis EE03515B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27959394A 1994-07-22 1994-07-22
US08/467,860 US5658884A (en) 1994-07-22 1995-06-06 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
PCT/US1995/008996 WO1996003138A1 (en) 1994-07-22 1995-07-18 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens

Publications (2)

Publication Number Publication Date
EE9700208A true EE9700208A (et) 1998-02-16
EE03515B1 EE03515B1 (et) 2001-10-15

Family

ID=26959766

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700208A EE03515B1 (et) 1994-07-22 1995-07-18 GnRH antagonist kasutamiseks gonadaalsteroid-sõltuva seisundi ravis

Country Status (29)

Country Link
EP (1) EP0769956B1 (et)
JP (1) JP3138477B2 (et)
CN (1) CN1137722C (et)
AP (1) AP775A (et)
AT (1) ATE190494T1 (et)
AU (1) AU691952B2 (et)
BG (1) BG63363B1 (et)
BR (1) BR9508718A (et)
CA (1) CA2195745C (et)
CY (1) CY2228B1 (et)
CZ (1) CZ291803B6 (et)
DE (1) DE69515666T2 (et)
DK (1) DK0769956T3 (et)
EE (1) EE03515B1 (et)
ES (1) ES2145286T3 (et)
FI (1) FI970244L (et)
GR (1) GR3033590T3 (et)
HU (1) HU218910B (et)
IL (1) IL114655A (et)
IS (1) IS4413A (et)
LV (1) LV11823B (et)
MX (1) MX9700574A (et)
NO (1) NO970257D0 (et)
NZ (1) NZ290554A (et)
OA (1) OA10730A (et)
PT (1) PT769956E (et)
RU (1) RU2181598C2 (et)
SK (1) SK282118B6 (et)
WO (1) WO1996003138A1 (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173592B1 (en) 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
PL201898B1 (pl) * 1999-09-23 2009-05-29 Zentaris Gmbh Zastosowanie antagonisty LH-RH w leczeniu endometriozy
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
GB0616111D0 (en) * 2006-06-16 2006-09-20 Ardana Bioscience Ltd Agents, methods and uses
EP2095818A1 (en) 2008-02-29 2009-09-02 AEterna Zentaris GmbH Use of LHRH antagonists at non-castrating doses
EP2307040B1 (en) * 2008-05-29 2015-09-09 Isr Immune System Regulation Ab Use of gnrh and sex hormones for treating viral disease, in particular hiv/aids
AU2016264034B2 (en) * 2015-05-18 2020-03-05 KaNDy Therapeutics Limited Dual NK-1/NK-3 receptor antagonists for the treatment of sex-hormone-dependent diseases
EA202092131A1 (ru) 2018-03-14 2020-11-27 Кэнди Терапьютикс Лимитед Новый фармацевтический препарат, содержащий двойные антагонисты рецептора nk-1/nk-3
EP3560555A1 (en) 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases
US12533358B1 (en) 2025-05-14 2026-01-27 Bayer Consumer Care Ag Methods of treatment with elinzanetant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5169932A (en) * 1989-10-30 1992-12-08 The Salk Institute For Biological Studies Gnrh analogs
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
US5681817A (en) * 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
CY2228B1 (en) 2003-04-18
IL114655A0 (en) 1995-11-27
FI970244A0 (fi) 1997-01-21
JP3138477B2 (ja) 2001-02-26
WO1996003138A1 (en) 1996-02-08
NZ290554A (en) 2000-08-25
PT769956E (pt) 2000-07-31
BG101158A (bg) 1997-09-30
SK7097A3 (en) 1997-11-05
EP0769956A4 (en) 1999-03-10
GR3033590T3 (en) 2000-09-29
AP775A (en) 1999-10-28
JPH10503203A (ja) 1998-03-24
FI970244A7 (fi) 1997-01-21
AU691952B2 (en) 1998-05-28
DE69515666T2 (de) 2000-07-06
CN1200674A (zh) 1998-12-02
BR9508718A (pt) 1997-12-30
ES2145286T3 (es) 2000-07-01
NO970257L (no) 1997-01-21
MX9700574A (es) 1997-12-31
OA10730A (en) 2001-06-07
ATE190494T1 (de) 2000-04-15
SK282118B6 (sk) 2001-11-06
FI970244L (fi) 1997-01-21
NO970257D0 (no) 1997-01-21
CN1137722C (zh) 2004-02-11
LV11823B (en) 1998-03-20
LV11823A (lv) 1997-08-20
HUT77127A (hu) 1998-03-02
AU3132095A (en) 1996-02-22
CA2195745C (en) 2005-03-29
CZ15097A3 (en) 1997-11-12
IS4413A (is) 1997-01-14
DE69515666D1 (de) 2000-04-20
CZ291803B6 (cs) 2003-06-18
IL114655A (en) 2005-08-31
HU218910B (hu) 2000-12-28
EP0769956B1 (en) 2000-03-15
BG63363B1 (bg) 2001-11-30
HU9700046D0 (en) 1997-02-28
EP0769956A1 (en) 1997-05-02
CA2195745A1 (en) 1996-02-08
AP9700913A0 (en) 1997-01-31
EE03515B1 (et) 2001-10-15
DK0769956T3 (da) 2000-06-05
RU2181598C2 (ru) 2002-04-27

Similar Documents

Publication Publication Date Title
PL321426A1 (en) Method of enzymaticaly treating wool
DE69534965D1 (de) Abscheidungsverfahren
FI944619A7 (fi) Aldolisointi-dehydratointimenetelmä
FI952060L (fi) Menetelmä atsitromysiinin annostamiseksi
NO952100D0 (no) Kabelavslutning
FI971568A7 (fi) Menetelmä resistenttien kasvainten hoitamiseksi
KR960012337A (ko) 에칭방법
FI963629L (fi) Sulakyllästysmenetelmä
DE69506072D1 (de) Strickverfahren
IL115809A0 (en) Method for treating anxiety
DE69523060D1 (de) Luziferase-markierungsmethode
DE69520558D1 (de) Halogenierungsverfahren
FI970670L (fi) Polttomenetelmä
FI972527L (fi) Pinnoitusmenetelmä
FI961879L (fi) Aromatisointimenetelmä
DE69522745D1 (de) Verfahren zum Abbau von Polysiloxanen
ID19570A (id) Metode merawat tanaman kotiledonous
DE69507032D1 (de) Chlorhydrin-verfahren
DK96392D0 (da) Modifikationsmetode
FI932571A7 (fi) Kemiallinen menetelmä
FI973173L (fi) Menetelmä kondensaatin käsittelemiseksi
DE69515106D1 (de) Alkylierungsverfahren
FI930022A7 (fi) Kemiallinen menetelmä
GB9404417D0 (en) Masking method
IS4285A (is) Aðferð við að hindra útfellingu

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20100718